APG-2449

· Ascentage Pharma Group Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for APG-2449, covering 2025-02-26 to 2025-06-18. Get the full timeline:

Most recent: Clinical Trial Update: APG-2449 in Patients With Advanced Solid Tumors [Phase 1]